Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07741643 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07741643
Sponsor: Vanderbilt-Ingram Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HNSCC,Larynx, Pharynx and Oral Cavity Squamous Cell Carcinoma Head and Neck Cancer Head and Neck Surgery

Start date: 2026-08-01
Primary completion: 2031-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.